21 January 2020 in ACS Chemical Neuroscience
23 September 2023 in CHEST Pulmonary
1 May 2020 in ACS Chemical Neuroscience
28 January 2019 in ACS Chemical Neuroscience
22 April 2026 in POCUS Journal
Background: Lung point of care ultrasound (POCUS) offers advantages over traditional imaging for diagnosing pulmonary conditions, with superior accuracy compared to chest X-ray and lower cost compared to computed tomography. Despite these benefits, widespread adoption is limited by operator dependency, moderate interrater reliability, and training requirements. Deep learning (DL) could potentially address these challenges, but the development of effective algorithms is hindered by the scarcity of comprehensive image repositories with proper metadata. Methods: We created an open-source dataset of lung POCUS images derived from a multi-center study involving 226 adult patients presenting to emergency departments with respiratory symptoms between March 2020 and April 2022. Images were acquired using a standardized scanning protocol (12-zone or modified 8-zone) with various POCUS devices. Three blinded researchers independently analyzed each image following consensus guidelines, with disagreements adjudicated to provide definitive interpretations. Videos were preprocessed to remove identifiers, and frames were extracted and standardized to 512×512 pixels using letterboxing to maintain aspect ratios. Results: The dataset contained 1,871 video clips comprising 324,027 frames extracted and standardized to 512×512 pixels. Half of the participants (50%) had COVID-19 pneumonia. Among all clips, 66% contained no abnormalities, 18% contained B-lines, 4.5% contained consolidations, 6.4% contained both B-lines and consolidations, and 5.2% had indeterminate findings. Pathological findings varied significantly by lung zone, with anterior zones more frequently normal and less likely to show consolidations compared to lateral and posterior zones. Discussion: This dataset represents a large, annotated lung POCUS repository and includes patients with and without COVID-19. The repository metadata and expert interpretations enhance its utility for DL applications. Despite limitations including potential device-specific characteristics and COVID-19 predominance, this repository provides a valuable resource for developing artificial intelligence tools to improve lung POCUS acquisition and interpretation.
18 November 2026 in POCUS Journal
Background: Artificial intelligence (AI) may improve ultrasound image acquisition and interpretation, but there have been few validation studies comparing AI-enabled machines to traditional measurement workflows. In this diagnostic comparison study, we evaluated AI-enabled point of care ultrasound (POCUS) compared to standard transthoracic echocardiography (TTE) measurements. Methods: Hospitalized adults at a single academic center who underwent both AI POCUS and standard TTE scans within 7 days of one another were eligible for inclusion. The AI POCUS software used convolutional neural network models to estimate left ventricular ejection fraction (LVEF), right ventricular fractional area change (RVFAC), valvular regurgitation, valvular stenosis, and inferior vena cava (IVC) diameter based on standard cardiac views. Agreement between AI POCUS and TTE was assessed using weighted Cohen’s κ and exploratory Bland-Altman analyses. Results: Seventy patients were included, with a median of 1 day (IQR 1–2 days, range 0–6 days) between AI POCUS and TTE examinations. AI POCUS demonstrated substantial agreement with TTE for LVEF (κ = 0.75, 95% CI 0.42–0.92). Agreement was lower for RVFAC (κ = -0.003), IVC diameter (κ = 0.382), aortic regurgitation (κ = 0.541), mitral regurgitation (κ = 0.438), tricuspid regurgitation (κ = 0.400), and aortic stenosis (κ = 0.086). Using a dichotomized threshold of LVEF <50% versus ≥50%, AI POCUS demonstrated 80.0% sensitivity and 88.6% specificity for detecting reduced LVEF. Conclusions: AI POCUS demonstrated substantial agreement with TTE for the estimation of LVEF. Agreement was lower for other echocardiographic parameters. These findings support the potential of AI POCUS for assessing left ventricular function.